Home Cart 0 Sign in  
X

[ CAS No. 100-06-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 100-06-1
Chemical Structure| 100-06-1
Chemical Structure| 100-06-1
Structure of 100-06-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 100-06-1 ]

Related Doc. of [ 100-06-1 ]

Alternatived Products of [ 100-06-1 ]

Product Details of [ 100-06-1 ]

CAS No. :100-06-1 MDL No. :MFCD00008745
Formula : C9H10O2 Boiling Point : -
Linear Structure Formula :- InChI Key :NTPLXRHDUXRPNE-UHFFFAOYSA-N
M.W : 150.17 Pubchem ID :7476
Synonyms :

Calculated chemistry of [ 100-06-1 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.22
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 43.13
TPSA : 26.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.98 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.93
Log Po/w (XLOGP3) : 1.74
Log Po/w (WLOGP) : 1.9
Log Po/w (MLOGP) : 1.44
Log Po/w (SILICOS-IT) : 2.16
Consensus Log Po/w : 1.83

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.14
Solubility : 1.09 mg/ml ; 0.00726 mol/l
Class : Soluble
Log S (Ali) : -1.91
Solubility : 1.85 mg/ml ; 0.0123 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.84
Solubility : 0.216 mg/ml ; 0.00144 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 100-06-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P301+P312+P330 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 100-06-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 100-06-1 ]
  • Downstream synthetic route of [ 100-06-1 ]

[ 100-06-1 ] Synthesis Path-Upstream   1~44

  • 1
  • [ 187336-16-9 ]
  • [ 253-82-7 ]
  • [ 100-06-1 ]
Reference: [1] Heterocycles, 1997, vol. 45, # 1, p. 1 - 5
  • 2
  • [ 187336-16-9 ]
  • [ 253-82-7 ]
  • [ 16499-37-9 ]
  • [ 100-06-1 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1998, vol. 46, # 2, p. 199 - 206
  • 3
  • [ 3290-99-1 ]
  • [ 100-06-1 ]
  • [ 829-35-6 ]
Reference: [1] Organic Letters, 2015, vol. 17, # 12, p. 2960 - 2963
  • 4
  • [ 100-06-1 ]
  • [ 99844-02-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 13, p. 3024 - 3028
[2] European Journal of Medicinal Chemistry, 2017, vol. 128, p. 1 - 12
[3] European Journal of Organic Chemistry, 2017, vol. 2017, # 29, p. 4247 - 4254
[4] European Journal of Organic Chemistry, 2017, vol. 2017, # 29, p. 4247 - 4254
  • 5
  • [ 75-15-0 ]
  • [ 100-06-1 ]
  • [ 532-11-6 ]
Reference: [1] Tetrahedron Letters, 2000, vol. 41, # 36, p. 6977 - 6980
  • 6
  • [ 100-06-1 ]
  • [ 532-11-6 ]
Reference: [1] Bulletin de la Societe Chimique de France, 1959, p. 1398,1400
  • 7
  • [ 100-06-1 ]
  • [ 27069-16-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 1, p. 273 - 280
[2] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 15, p. 4649 - 4659
[3] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 17, p. 4372 - 4376
  • 8
  • [ 100-06-1 ]
  • [ 105-58-8 ]
  • [ 2881-83-6 ]
YieldReaction ConditionsOperation in experiment
95%
Stage #1: With sodium hydride In tetrahydrofuranReflux
Stage #2: With acetic acid In tetrahydrofuran
General procedure: To a stirred mixture of sodium hydride (3 mol equiv) washed with hexane (3 .x. 15 ml), and diethyl carbonate (4 mol equiv) in 50 mL of tetrahydrofuran (THF) was added drop wise appropriately substituted acetophenone (1 mol equiv) over 30 min. Reaction mixture was refluxed for 3-4 h till color changed to dark brown and monitored by TLC (10percent ethyl acetate/hexanes). The reaction mixture was cooled and acidified with 5 mL glacial acetic acid followed by addition 100 mL of ice cold dilute HCl solution. The aqueous layer was extracted with ethyl acetate (3 .x. 75 ml); combined organic phase was washed with saturated sodium bicarbonate, brine and water, dried over anhydrous Na2SO4 and evaporated in vacuo, yielded the desired product as viscous mass in excellent yield. The compounds were characterized on the basis of their 1H NMR and 13C NMR spectra as reported in the literature.
87% With sodium hydride In toluene; mineral oil General procedure: The substrate b-ketoesters 10 a–n were either purchased or synthesized following published procedures. Some benzoylacetates were commercially available. Ethyl 3-oxo-3-phenyl propanoate (10a) was purchased. The reaction of benzoylacetates 10 b–n was prepared as described in previous reports. 25–27 A solution of a substituted acetophenone 8 a–n (0.05 mol) dissolved in toluene (50 mL) was added dropwise to a solution containing diethyl carbonate (9) (0.10 mol) and sodium hydride (0.15 mol 60percent dispersion in mineral oil). The mixture was stirred at room temperature, and then refluxed for 30 min. The mixture was poured into ice water,acidified with glacial acetic acid, and extracted with EtOAc (3x100 mL). The EtOAc extract was then dried over anhydrous MgSO4. After removal of the solvent in vacuo, the crude products were purified by silica gel column chromatography eluting with dichloromethane to afford benzoylacetates 10 b–n. All synthetic compounds were in agreement with 1H NMR, 13C NMR, IR and mass spectroscopic data.
Reference: [1] European Journal of Organic Chemistry, 2017, vol. 2017, # 31, p. 4543 - 4547
[2] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 14, p. 4237 - 4244
[3] Angewandte Chemie - International Edition, 2012, vol. 51, # 34, p. 8661 - 8664
[4] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 17, p. 5064 - 5075
[5] European Journal of Organic Chemistry, 2012, # 35, p. 6976 - 6985
[6] Organic Letters, 2014, vol. 16, # 19, p. 5152 - 5155
[7] Angewandte Chemie - International Edition, 2015, vol. 54, # 9, p. 2788 - 2791[8] Angew. Chem., 2015, vol. 127, # 9, p. 2829 - 2833,5
[9] European Journal of Organic Chemistry, 2014, vol. 2014, # 25, p. 5591 - 5597
[10] Beilstein Journal of Organic Chemistry, 2017, vol. 13, p. 1950 - 1956
[11] Journal of the American Chemical Society, 1941, vol. 63, p. 2252
[12] Helvetica Chimica Acta, 1974, vol. 57, # 7, p. 2201 - 2209
[13] Journal of the American Chemical Society, 1961, vol. 83, p. 1951 - 1955
[14] Bulletin of the Chemical Society of Japan, 1988, vol. 61, # 6, p. 2277 - 2280
[15] Journal of Medicinal Chemistry, 1997, vol. 40, # 3, p. 322 - 330
[16] Journal of Medicinal Chemistry, 1997, vol. 40, # 20, p. 3217 - 3227
[17] Journal of Medicinal Chemistry, 1997, vol. 40, # 14, p. 2266 - 2275
[18] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 20, p. 4520 - 4525
[19] Patent: WO2006/34094, 2006, A1, . Location in patent: Page/Page column 22-23
[20] Patent: WO2006/34234, 2006, A1, . Location in patent: Page/Page column 16
[21] Patent: US2008/132710, 2008, A1, . Location in patent: Page/Page column 8
[22] Chemistry - A European Journal, 2008, vol. 14, # 27, p. 8082 - 8085
[23] Patent: WO2006/34085, 2006, A1, . Location in patent: Page/Page column 13
[24] Patent: US6348618, 2002, B1, . Location in patent: Page column 10
[25] Angewandte Chemie - International Edition, 2011, vol. 50, # 32, p. 7304 - 7307
[26] Journal of the American Chemical Society, 2013, vol. 135, # 32, p. 11692 - 11695
[27] Tetrahedron Letters, 2014, vol. 55, # 48, p. 6534 - 6537
[28] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 6, p. 1177 - 1181
[29] European Journal of Organic Chemistry, 2015, vol. 2015, # 17, p. 3656 - 3660
[30] Advanced Synthesis and Catalysis, 2015, vol. 357, # 14-15, p. 3076 - 3080
[31] Tetrahedron Letters, 2016, vol. 57, # 27-28, p. 3024 - 3028
[32] Organic Letters, 2016, vol. 18, # 20, p. 5408 - 5411
[33] Chemical Communications, 2017, vol. 53, # 58, p. 8136 - 8139
[34] Acta Poloniae Pharmaceutica - Drug Research, 2017, vol. 74, # 5, p. 1427 - 1436
[35] Organic Letters, 2017, vol. 19, # 23, p. 6344 - 6347
[36] Journal of Medicinal Chemistry, 2018, vol. 61, # 3, p. 791 - 803
[37] Russian Journal of General Chemistry, 2017, vol. 87, # 12, p. 2951 - 2960[38] Zh. Obshch. Khim., 2017, vol. 87, # 12, p. 2951 - 2960
[39] Organic and Biomolecular Chemistry, 2018, vol. 16, # 25, p. 4683 - 4687
[40] Organic Letters, 2018, vol. 20, # 20, p. 6349 - 6353
  • 9
  • [ 41233-93-6 ]
  • [ 100-06-1 ]
  • [ 105-58-8 ]
  • [ 2881-83-6 ]
Reference: [1] Patent: US6124341, 2000, A,
[2] Patent: US2006/63825, 2006, A1, . Location in patent: Page/Page column 9
  • 10
  • [ 100-06-1 ]
  • [ 2881-83-6 ]
Reference: [1] Journal of the American Chemical Society, 1948, vol. 70, p. 2755,2757
[2] Patent: US5342845, 1994, A,
  • 11
  • [ 623-53-0 ]
  • [ 100-06-1 ]
  • [ 2881-83-6 ]
Reference: [1] Chemical Communications, 2011, vol. 47, # 39, p. 11143 - 11145
  • 12
  • [ 95-92-1 ]
  • [ 100-06-1 ]
  • [ 2881-83-6 ]
Reference: [1] European Journal of Medicinal Chemistry, 2013, vol. 59, p. 176 - 182
  • 13
  • [ 33868-76-7 ]
  • [ 100-06-1 ]
  • [ 81874-58-0 ]
  • [ 2881-83-6 ]
Reference: [1] Journal of Organic Chemistry, 1982, vol. 47, # 16, p. 3027 - 3038
  • 14
  • [ 100-06-1 ]
  • [ 109-94-4 ]
  • [ 2881-83-6 ]
Reference: [1] Organometallics, 2012, vol. 31, # 3, p. 966 - 975
  • 15
  • [ 100-06-1 ]
  • [ 105-58-8 ]
  • [ 27835-06-9 ]
  • [ 2881-83-6 ]
Reference: [1] Chemistry - An Asian Journal, 2016, vol. 11, # 3, p. 395 - 400
  • 16
  • [ 100-06-1 ]
  • [ 41068-36-4 ]
  • [ 157487-30-4 ]
Reference: [1] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2004, vol. 43, # 6, p. 1335 - 1338
  • 17
  • [ 104-92-7 ]
  • [ 108-24-7 ]
  • [ 16740-73-1 ]
  • [ 100-06-1 ]
Reference: [1] Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1946, vol. 223, p. 159
  • 18
  • [ 7446-70-0 ]
  • [ 104-92-7 ]
  • [ 108-24-7 ]
  • [ 16740-73-1 ]
  • [ 100-06-1 ]
Reference: [1] Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1946, vol. 223, p. 159
  • 19
  • [ 100-06-1 ]
  • [ 35310-75-9 ]
YieldReaction ConditionsOperation in experiment
98% With N-Bromosuccinimide; sulfuric acid In water at 60℃; for 5 h; Ketone 7a (5.0 g, 33.3 mmol) and N-bromosuccinimide (NBS, 5.9 g, 33.3 mmol) were added to 100 mL water and heated to 60°C, followed by slow drop-wise addition of 40percent H2SO4 (66.7 mmol, 8.9 mL). The resulting mixture was continuously stirred for 5 h. When the mixture was cooled to room temperature, isolation was performed using AcOEt (60 mL × 3) extraction. The combined organic extracts were washed with saturated NaHCO3, dried over MgSO4 and evaporated to yield a crude product 7b (7.5 g, 98percent) as a white solid. Rf 0.85 (PE/AcOEt, 3:1). 1H NMR (400 MHz, DMSO–d6) δ: 3.09 (3H, s), 3.93 (3H, s), 3.95 (6H, s), 7.92 (1H, d, J = 8.9 Hz), 7.97 (1H, dd, J = 2.1 Hz, 8.9 Hz), 8.10 (2H, d, J = 2.1 Hz); LC–MS m/z: 230.9 [M+H]+.
97% With N-Bromosuccinimide; iodine In acetonitrile for 12 h; Darkness General procedure: To a reaction tube charged with NBS (1.5 equiv, 0.3 mmol), catalyst (10 molpercent, 0.02 mmol) and CH3CN (1.0 mL),was added para-chloroanisole 1a (0.2 mmol). After being stirred at room temperature for 12 h in dark, the reaction was quenched by saturated aq. solution of Na2S2O3 (2 mL). The resulting mixture was extracted by ethyl acetate (3 5 mL). The combined organic extracts were washed by brine (10 mL), dried over Na2SO4 and filtered through a pad of Celite. The filtrate was concentrated under reduced pressure and the residuewas purified by flash chromatography on a silica gel column with petroleum ether/dichloromethane (5:1) as the eluent to give 4.3.1. 2-Bromo-4-chloroanisole (2a)
96% With iodine pentoxide; potassium bromide In water at 20℃; for 10 h; General procedure: A mixture of arene (0.5 mmol), I2O5 (334 mg, 1.0 mmol), and KBr (148 mg, 1.25 mmol) was dissolved in 2mL of H2O. The reaction was complete after stirring for the indicated time at room temperature. The mixture was extracted by ethyl acetate and concentrated under reduced pressure, and the mixture was purified by flash column chromatography (silica gel) to afford the desired product.
88% at 20℃; for 1.16667 h; Inert atmosphere Bromine (0.54 mL, 10.5 mmol) in acetic acid (1.7 mL) was added dropwise to a mixture of 4-methoxyacetophenone (758 mg,5 mmol) and sodium acetate (1.28 g, 15.5 mmol) in acid acetic (10 mL) at room temperature over 10 min. The reaction mixture was stirred for 1 h at room temperature. H2O (30 mL) was added and the solid was filtered, washed with H2O and dried under high vacuum to afford 3-bromo-4-methoxyacetophenone 11b as a white solid in 88percent yield (1.01 g, 4.4 mmol).

Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 17, p. 4372 - 4376
[2] Tetrahedron, 2017, vol. 73, # 50, p. 7105 - 7114
[3] Synthetic Communications, 2014, vol. 44, # 2, p. 181 - 187
[4] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 13, p. 3618 - 3628
[5] Organic Letters, 2013, vol. 15, # 9, p. 2108 - 2111
[6] Tetrahedron Letters, 2006, vol. 47, # 49, p. 8693 - 8697
[7] Organic Letters, 2009, vol. 11, # 2, p. 365 - 368
[8] Tetrahedron Letters, 2006, vol. 47, # 27, p. 4707 - 4710
[9] New Journal of Chemistry, 2016, vol. 40, # 10, p. 8198 - 8201
[10] Huaxue Xuebao, 1959, vol. 25, p. 277,285[11] Chem.Abstr., 1960, p. 17306
[12] Chemische Berichte, 1953, vol. 86, p. 1556,1560
[13] Chemische Berichte, 1957, vol. 90, p. 1922,1926
[14] Journal of the American Chemical Society, 1984, vol. 106, # 5, p. 1361 - 1372
[15] Synlett, 2014, vol. 25, # 12, p. 1769 - 1775
  • 20
  • [ 3319-15-1 ]
  • [ 35310-75-9 ]
  • [ 100-06-1 ]
Reference: [1] Synthesis, 2009, # 6, p. 903 - 908
[2] Tetrahedron Letters, 2001, vol. 42, # 3, p. 445 - 448
  • 21
  • [ 3319-15-1 ]
  • [ 104-92-7 ]
  • [ 35310-75-9 ]
  • [ 94670-25-4 ]
  • [ 100-06-1 ]
Reference: [1] Tetrahedron Letters, 2005, vol. 46, # 52, p. 8975 - 8979
[2] Bulletin of the Chemical Society of Japan, 2005, vol. 78, # 9, p. 1677 - 1684
  • 22
  • [ 3319-15-1 ]
  • [ 104-92-7 ]
  • [ 35310-75-9 ]
  • [ 100-06-1 ]
Reference: [1] Synlett, 2003, # 7, p. 951 - 954
  • 23
  • [ 100-06-1 ]
  • [ 104-92-7 ]
  • [ 35310-75-9 ]
  • [ 21702-84-1 ]
Reference: [1] Journal of Organic Chemistry, 2002, vol. 67, # 13, p. 4487 - 4493
  • 24
  • [ 100-06-1 ]
  • [ 2657-25-2 ]
Reference: [1] European Journal of Medicinal Chemistry, 2015, vol. 101, p. 627 - 639
  • 25
  • [ 100-06-1 ]
  • [ 455-91-4 ]
Reference: [1] Tetrahedron Letters, 1996, vol. 37, # 20, p. 3591 - 3594
[2] Chemical Communications, 2000, # 14, p. 1323 - 1324
[3] Molecules, 2009, vol. 14, # 7, p. 2394 - 2409
  • 26
  • [ 100-06-1 ]
  • [ 6343-93-7 ]
Reference: [1] Organic Preparations and Procedures International, 1995, vol. 27, # 5, p. 552 - 555
  • 27
  • [ 616-38-6 ]
  • [ 100-06-1 ]
  • [ 22027-50-5 ]
YieldReaction ConditionsOperation in experiment
98% With sodium hydride In toluene for 4 h; Inert atmosphere; Reflux General procedure: To a dried three-necked flask equipped with a dropping funnel, a condenser, and a magnetic stirrer, dimethyl carbonate 5 (2 eq), NaH 60percent (2.8 eq) and dry toluene (2 M) were added. The mixture was heated to reflux under nitrogen. A solution of the corresponding aryl-methyl-ketone (4a–h) (1 eq) in dry toluene (2 M) was added dropwise over 1 h. The resulting reaction mixture was refluxed for 3 h, and then was cooled to 0 °C and glacial acetic acid was added dropwise until pH 4. The solid obtained was filtered and subsequently dissolved in hot water. The aqueous phase was extracted with EtOAc(×3). The combined organic layers were washed with brine, dried over sodium sulphate, and concentrated in vacuo to give the desired Aryl β-Keto ester, which was pure enough to be used for the next step without purification.
98% With sodium hydride In toluene; mineral oil for 0.5 h; Reflux General procedure: In a dry two neck flask equipped with a reflux condenser and rubber septum and a stir bar, NaH (60percent wt in mineral oil, 4.0 g, 100 mmol) was suspended in toluene (8 mL) and dimethylcarbonate (9.1 g, 100 mmol, 2.5 eq) was added. The mixture was heated to reflux and acetophenone (4.8 g, 40 mmol, 1.0 eq) in toluene (20 mL) was added dropwise. The reaction mixture was stir for 0.5 h when hydrogen evolution had ceased.The suspension was cooled to 0 °C, diluted with EtOAc (150 mL) and carefully quenched with MeOH (10 mL), followed by H2O, and then acidified to pH < 5 using 1N HCl. The organic layer is separated and then washed with H2O (200 mL) then brine (100 mL), and dried over MgSO4, and concentrated in vacuo. The resulting biphasic liquid was partitioned between MeCN (20 mL) and hexanes (10 mL) and then washed with hexanes (25 mL x 2) and concentrated in vacuo to give the β-ketoesters. Dicarbonyl compound (6mmol) was dissolved in MeOH (6 mL) and then cooled in a brine-ice bath. Then, 30percent KOH in MeOH (6 mL) solution was added dropwise an the mixture was allowed to stir for 2 minutes after which a solution of iodobenzene diacetate (6 mmol) was added dropwise and the resulting mixture was allowed to stir for 1 hr and then poured onto icewater (100 mL). The suspension is then extracted with CH2Cl2 (50 mL x 3). The combined extracts were dried over MgSO4, filtered through Buchner funnel, then concentrated in vacuo to approximately one third of the original volume. The ylide was slowly precipitated using Et2O and/or hexanes, and cooled to 0 °C and isolated by filtration.
87% for 0.166667 h; Reflux Step 1.
Methyl 3-(4-methoxyphenyl)-3-oxopropanoate
Into a 500-mL 3-necked round-bottom flask, was placed a solution of 1-(4-methoxyphenyl)ethanone (30 g, 200 mmol, 1.00 equiv) in dimethyl carbonate (50 mL).
To the above was added NaH (13.6 g, 340 mmol, 1.70 equiv, 60percent) in several batches.
The resulting solution was allowed to react, with stirring, for 10 min while the temperature was maintained at reflux.
It was poured into 400 mL of ice-water to get a solution, then washed with ether (50 mL*2), acidified with AcOH, extracted with ethyl acetate (200 mL*3), and the ethyl acetate layers were washed with saturated NaHCO3 and dried over Na2SO4.
The solution was concentrated to provide 37 g (87percent) of methyl 3-(4-methoxyphenyl)-3-oxopropanoate as yellow oil.
61% With sodium hydride In toluene; mineral oil at 20 - 110℃; for 7 h; Inert atmosphere General procedure: In a three-necked round bottomed flask equipped with a reflux condenser and a magnetic stirrer, NaH (4equiv, 60percent mineral oil dispersion), was placed under nitrogen and washed with toluene (3×10mL). Next the solution of dimethyl carbonate (3equiv) in toluene (50mL) was added. The appropriate derivative of acetophenone (10g) in toluene (50mL) was added dropwise over 1h to the resultant suspension, with stirring at rt. The reaction mixture was subsequently diluted with toluene (250mL) and stirred vigorously at 105–110°C for the time given in Table 1. The resulting mixture was cooled to rt, and glacial acetic acid (8mL) was added dropwise until a heavy, pasty solid appeared. This was treated with a solution of conc. HCl (30mL) in ice water (200mL). The separated aqueous solution was extracted with AcOEt (3×200mL). The organic layers were neutralized by extraction with saturated NaHCO3 (2×200mL) and dried over anhydrous Na2SO4. The volatiles were then removed under reduced pressure and the resultant crude oil was purified by vacuum distillation to give the appropriate β-keto ester as a keto-enol tautomer.
13.18 g
Stage #1: With sodium hydride In tetrahydrofuran for 2 h;
Stage #2: With potassium hydride In tetrahydrofuran for 1.5 h;
To an NaH (10.4 g, used after washing with dry hexane) suspension(50 mL, THF), (MeO)2CO (15.9 g) and p-methoxyacetophenon(13 g) were added dropwise over 2 h. Next, KH (ca. 0.5 g) wasadded and the resulting mixture was stirred for 1.5 h and thenquenched with AcOH (1000 mL). Extraction, distillation(423 K/1 mmHg), and subsequent purification via column chromatographygave 2 (13.18 g) as a yellow oily product (1H NMR:(keto-form) d 7.91 (d, J = 8.9 Hz, 2H), 6.93 (d, J = 6.9 Hz, 2H), 3.94(s, 2H), 3.86 (s, 3H), 3.73 (s, 3H), (enol-form) d 7.72 (d, J = 6.0 Hz,2H), 6.9 (d, J = 6.9 Hz, 2H), 5.57 (s, 1H), 3.86 (s, 1H), 3.83 (s, 3H),3.73 (s, 3H)).

Reference: [1] Chemistry - A European Journal, 2017, vol. 23, # 41, p. 9716 - 9720
[2] Chemistry - A European Journal, 2018, vol. 24, # 32, p. 8092 - 8097
[3] Molecules, 2015, vol. 20, # 9, p. 17275 - 17287
[4] Synthesis (Germany), 2016, vol. 48, # 5, p. 772 - 782
[5] Angewandte Chemie - International Edition, 2017, vol. 56, # 43, p. 13319 - 13323[6] Angew. Chem., 2017, vol. 129, p. 13504 - 13508,5
[7] Chemical and Pharmaceutical Bulletin, 1993, vol. 41, # 4, p. 643 - 648
[8] Chemical Communications, 2011, vol. 47, # 39, p. 11143 - 11145
[9] Synthesis, 2003, # 15, p. 2405 - 2409
[10] Patent: US2012/277224, 2012, A1, . Location in patent: Page/Page column 72
[11] Advanced Synthesis and Catalysis, 2003, vol. 345, # 1-2, p. 261 - 274
[12] Molecules, 2004, vol. 9, # 3, p. 135 - 157
[13] Chemical Communications (Cambridge, United Kingdom), 2018, vol. 54, # 82, p. 11602 - 11605
[14] Tetrahedron Asymmetry, 2013, vol. 24, # 15-16, p. 925 - 936
[15] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 20, p. 4520 - 4525
[16] Journal of the American Chemical Society, 2007, vol. 129, # 37, p. 11583 - 11592
[17] Organic Letters, 2009, vol. 11, # 18, p. 4176 - 4179
[18] Patent: EP2168959, 2010, A1, . Location in patent: Page/Page column 159
[19] Patent: EP2168960, 2010, A1, . Location in patent: Page/Page column 109
[20] Patent: US6348618, 2002, B1, . Location in patent: Page column 10
[21] Organic and Biomolecular Chemistry, 2011, vol. 9, # 3, p. 739 - 743
[22] Journal of Agricultural and Food Chemistry, 2010, vol. 58, # 5, p. 2664 - 2667
[23] Chemistry - A European Journal, 2008, vol. 14, # 32, p. 9864 - 9867
[24] Chemical Communications, 2012, vol. 48, # 17, p. 2340 - 2342
[25] Organic Letters, 2012, vol. 14, # 6, p. 1412 - 1415
[26] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 1, p. 375 - 381
[27] Organic Letters, 2013, vol. 15, # 24, p. 6222 - 6225
[28] Tetrahedron Letters, 2014, vol. 55, # 48, p. 6534 - 6537
[29] Organic Letters, 2014, vol. 16, # 20, p. 5410 - 5413
[30] Journal of the American Chemical Society, 2014, vol. 136, # 46, p. 16120 - 16123
[31] Tetrahedron, 2014, vol. 70, # 44, p. 8405 - 8412
[32] Journal of Medicinal Chemistry, 2016, vol. 59, # 7, p. 3272 - 3302
[33] Advanced Synthesis and Catalysis, 2016, vol. 358, # 12, p. 1934 - 1941
[34] Tetrahedron Asymmetry, 2016, vol. 27, # 14-15, p. 657 - 662
[35] Angewandte Chemie - International Edition, 2017, vol. 56, # 32, p. 9577 - 9581[36] Angew. Chem., 2017, vol. 129, # 32, p. 9705 - 9709,5
[37] Journal of Organic Chemistry, 2017, vol. 82, # 20, p. 10883 - 10897
[38] Organic Letters, 2017, vol. 19, # 19, p. 5130 - 5133
[39] Synthesis (Germany), 2016, vol. 48, # 9, p. 1359 - 1370
[40] Chinese Journal of Chemistry, 2017, vol. 35, # 11, p. 1665 - 1668
[41] Journal of the American Chemical Society, 2018, vol. 140, # 44, p. 14647 - 14654
[42] Journal of the American Chemical Society, 2018, vol. 140, # 50, p. 17666 - 17673
  • 28
  • [ 246140-20-5 ]
  • [ 100-06-1 ]
  • [ 22027-50-5 ]
YieldReaction ConditionsOperation in experiment
77% With sodium hydride In tetrahydrofuranReflux General procedure: Substrates 1g-j and 1l were prepared adaptedfrom a previously reported procedure with some modications: toa solution of ketone (20 mmol) in THF (80 mL) was added methyldicarbonate (60 mmol) and NaH (40 mmol, 60percent). The reactionmixture was reuxed until TLC indicated complete consumption ofthe ketone. After cooling, the reaction mixture was poured into ice-water (100 mL), acidied with aqueous HCl (3 M) to pH 2e3 andextracted with EA (100 mL 3). The combined organic layer wasdried over Na2SO4 and evaporated under reduced pressure. Thedesired pure product was obtained by silica gel chromatographyusing a mixture of EA/PE (v/v 1/9) as eluent.
Reference: [1] Tetrahedron, 2018, vol. 74, # 17, p. 2107 - 2114
  • 29
  • [ 108-20-3 ]
  • [ 616-38-6 ]
  • [ 100-06-1 ]
  • [ 22027-50-5 ]
Reference: [1] Patent: US5204248, 1993, A,
  • 30
  • [ 124-38-9 ]
  • [ 100-06-1 ]
  • [ 74-88-4 ]
  • [ 22027-50-5 ]
Reference: [1] Green Chemistry, 2011, vol. 13, # 2, p. 376 - 383
  • 31
  • [ 100-06-1 ]
  • [ 6298-96-0 ]
  • [ 6298-96-0 ]
Reference: [1] Angewandte Chemie - International Edition, 2003, vol. 42, # 44, p. 5472 - 5474
[2] Journal of the Chemical Society. Perkin Transactions 2, 2000, # 7, p. 1339 - 1347
[3] Chemical Communications, 2010, vol. 46, # 30, p. 5500 - 5502
[4] Journal of the American Chemical Society, 2018, vol. 140, # 6, p. 2024 - 2027
  • 32
  • [ 100-06-1 ]
  • [ 6298-96-0 ]
Reference: [1] Journal of Organic Chemistry, 2006, vol. 71, # 10, p. 3998 - 4001
[2] Tetrahedron, 1994, vol. 50, # 15, p. 4399 - 4428
[3] Advanced Synthesis and Catalysis, 2015, vol. 357, # 8, p. 1732 - 1740
  • 33
  • [ 100-06-1 ]
  • [ 6298-96-0 ]
Reference: [1] European Journal of Organic Chemistry, 2015, vol. 2015, # 24, p. 5393 - 5401
  • 34
  • [ 70249-37-5 ]
  • [ 100-06-1 ]
  • [ 6298-96-0 ]
  • [ 99-06-9 ]
Reference: [1] Chemical Communications, 2013, vol. 49, # 2, p. 161 - 163
  • 35
  • [ 100-06-1 ]
  • [ 75172-66-6 ]
Reference: [1] Advanced Synthesis and Catalysis, 2017, vol. 359, # 20, p. 3665 - 3673
  • 36
  • [ 100-06-1 ]
  • [ 74457-86-6 ]
Reference: [1] Patent: CN103922904, 2016, B,
  • 37
  • [ 100-06-1 ]
  • [ 3883-94-1 ]
YieldReaction ConditionsOperation in experiment
62.1%
Stage #1: With N-Bromosuccinimide In ethanol at 40℃; for 3 h; Large scale
Stage #2: With hexamethylenetetramine In ethanol at 25℃; for 3 h; Large scale
Stage #3: With hydrogenchloride In ethanol at 25℃; for 12 h; Large scale
The starting material for this synthesis is 1-(4-methoxyphenyl)-ethanone: [0089] The first step is allylic bromination. Anhydrous ethanol (400 kg) and 1-(4-methoxyphenyl)ethanone (42 kg) were added to a 1000 L vessel and stirred at 25° C. Then N-bromosuccinimide (56 kg) was added potionwise. This mixture was stirred at 40° C. for 3 hours, after which the mixture was cooled to 25° C. Next, hexamethylenetetramine (38 kg) was added potionwise. This mixture was stirred at 25° C. for 3 hours and then filtered. Anhydrous ethanol (560 kg) was added to the precipitated solid in a 1000 L vessel, and the mixture was stirred at 25° C. Concentrated hydrogen chloride (HCl, 35 kg) was then added for acid hydrolysis, and stirring continued at 25° C. for 12 hours. After this time, the volume was concentrated to , and the temperature was reduced to 5° C. for crystallization. The product was filtered and dried. This product is intermediate 2-amino-1-(4-methoxyphenyl)ethanone hydrochloride (35 kg): The yield of 2-amino-1-(4-methoxyphenyl)ethanone hydrochloride, based on starting product 1-(4-methoxyphenyl)ethanone, was 62.1percent.
Reference: [1] Patent: US2014/134283, 2014, A1, . Location in patent: Paragraph 0088-0089
[2] Journal of Pharmaceutical Sciences, 2014, vol. 103, # 9, p. 2797 - 2808
[3] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 3, p. 849 - 853
[4] Journal of Medicinal Chemistry, 2017, vol. 60, # 22, p. 9275 - 9289
  • 38
  • [ 100-06-1 ]
  • [ 82640-04-8 ]
Reference: [1] Patent: WO2011/132194, 2011, A1,
  • 39
  • [ 100-06-1 ]
  • [ 148990-17-4 ]
Reference: [1] Chemical Biology and Drug Design, 2017, vol. 90, # 5, p. 936 - 942
  • 40
  • [ 26537-19-9 ]
  • [ 100-06-1 ]
  • [ 70356-09-1 ]
YieldReaction ConditionsOperation in experiment
95% With potassium methanolate In toluene at 110℃; for 2 h; condensation with various bases In a reaction flask with a 30 ml toluene and the base were provided under a blanket of inert gas. 20 mmole 4-tert-Butyl benzoic acid methyl ester (TBBM) and 20 mmole p-methoxy acetophenone (pMAc) was added. The mixture was stirred at about 110°C/ 1 bar while alcohol and toluene was slowly distilled off (toluene was occasionally replenished to maintain 20 ml volume). After complete conversion of TBBM and pMAc the reaction mixture was cooled and acidified with 2M acetic acid. An aliquot was analyzed by HPLC for the chemical yield of 4-te/f-Butyl-4'-methoxydibenzoylmethane. The results are given in table 1. Table 1 : ResultsAs can be seen from the results in table 1 the use of a potassium alcoholate results in higher yields and shorter reaction times compared to the use of other alkali or earth alkali alcoholates.Furthermore, the potassium salt did not crystallize and remained homogeneously dissolved in toluene whereas the sodium, magnesium and the lithium salt formed a crystalline inhomogeneous mixture
78% With sodium amide In 5,5-dimethyl-1,3-cyclohexadiene at 95 - 100℃; for 5 h; 5), the condensation reaction with p-tert-butyl benzoate and p-methoxy acetophenone as raw materials,With sodium amide as catalyst,Xylene as solvent,The molar ratio of p-methoxyacetophenone to methyl p-tert-butylbenzoate was 1: 1.4,The reaction temperature was 100 ° C,Reaction time is 5h,Eventually get Avobenzone.The reaction temperature was 95 ° C,The molar ratio of p-methoxyacetophenone to methyl p-tert-butylbenzoate was 1: 1.4.The final yield of avobenzone was 78percentThe purity is 99percent.
Reference: [1] Patent: WO2012/84770, 2012, A1, . Location in patent: Page/Page column 8-9
[2] Patent: CN104876814, 2017, B, . Location in patent: Paragraph 0021; 0028; 0035
[3] Research on Chemical Intermediates, 2013, vol. 39, # 6, p. 2311 - 2320
[4] Journal of the American Chemical Society, 2010, vol. 132, # 7, p. 2160 - 2162
  • 41
  • [ 92279-83-9 ]
  • [ 100-06-1 ]
  • [ 70356-09-1 ]
YieldReaction ConditionsOperation in experiment
91% With potassium methanolate In toluene for 1.75 h; Heating In a reaction flask with a stirrer was provided at ambient temperature under a blanket of inert gas: 16 ml toluene, 24 mmole base and 20.4 mmole 4-tert. butyl benzoic acid methylester (TBBM), respectively 20.4 mmole 4-tert. butyl benzoic acid fe/f.-butyl ester (TBBT) as indicated in table 3. The resulting reaction mixture was heated to boiling. Afterwards a 3 molar solution of p-methoxy acetophenone (pMAc) in toluene was added within 1 h under slow distillation of a mixture of methanol and/ or te/t-butanol and toluene at 1 bar. The mixture was stirred for x additional hours as indicated in table 3. The reaction mixture was occasionally replenished to 20 ml volume by addition of toluene. The reaction mixture was cooled and acidified with 2M acetic acid. An aliquot was analyzed by HPLC for the chemical yield of 4-te/f-butyl-4'-methoxydibenzoylmethane. The results are presented in table 3.Table 3Base Ester Appearance of reaction mixture time [h] Yield [molepercent]KOMe TBBT homogeneous 1.75 91KOtBu TBBT homogeneous 2 85KOtBu TBBM homogeneous 3 92NaOtBu TBBT inhomogeneous 1.75 63NaOMe TBBT inhomogeneous 4 80NaOtBu TBBM inhomogeneous 3 85TBBT = 4-(1 ,1-dime1 hylethyl)-benzoic acid te/f-butyl est er TBBM = 4-(1 , 1-dimethylethyl)-benzoic acid methyl esterAs can be retrieved from table 3 highest yields of butyl methoxydibenzoylmethane were achieved with either the te/f-butylester TBBT and potassium methylate or the methylester TBBM with potassium te/f-butylate, whereas the combination of the te/f-butylester TBBT with potassium te/f-butylate resulted in lower yields.Furthermore, as can be retrieved from table 3, the use of the respective sodium alcoholate resulted in significant lower yields compared to the use of the respective potassium alcoholate. Furthermore, the use of sodium alcoholate resulted in inhomogeneous badly stirrable reaction mixtures.
Reference: [1] Patent: WO2012/84770, 2012, A1, . Location in patent: Page/Page column 10-11
  • 42
  • [ 100-06-1 ]
  • [ 206055-86-9 ]
Reference: [1] Patent: EP2308838, 2011, A1,
[2] Organic and Biomolecular Chemistry, 2015, vol. 13, # 11, p. 3416 - 3431
[3] Organic and Biomolecular Chemistry, 2015, vol. 13, # 40, p. 10162 - 10178
[4] Chemical Biology and Drug Design, 2017, vol. 89, # 4, p. 634 - 638
  • 43
  • [ 100-06-1 ]
  • [ 925006-96-8 ]
Reference: [1] European Journal of Pharmaceutical Sciences, 2011, vol. 42, # 3, p. 180 - 191
[2] European Journal of Medicinal Chemistry, 2013, vol. 64, p. 42 - 53
[3] Letters in Drug Design and Discovery, 2018, vol. 15, # 6, p. 576 - 582
[4] European Journal of Medicinal Chemistry, 2018, vol. 159, p. 90 - 103
[5] Journal of Enzyme Inhibition and Medicinal Chemistry, 2018, vol. 33, # 1, p. 1352 - 1361
  • 44
  • [ 18711-13-2 ]
  • [ 100-06-1 ]
  • [ 1037184-44-3 ]
Reference: [1] Patent: WO2016/57698, 2016, A1, . Location in patent: Page/Page column 33
[2] Patent: WO2017/172368, 2017, A1, . Location in patent: Paragraph 0134
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 100-06-1 ]

Aryls

Chemical Structure| 586-37-8

[ 586-37-8 ]

3'-Methoxyacetophenone

Similarity: 0.98

Chemical Structure| 43113-94-6

[ 43113-94-6 ]

1-(3-Methoxy-5-methylphenyl)ethanone

Similarity: 0.98

Chemical Structure| 37951-49-8

[ 37951-49-8 ]

3'-Methoxypropiophenone

Similarity: 0.98

Chemical Structure| 611-94-9

[ 611-94-9 ]

(4-Methoxyphenyl)(phenyl)methanone

Similarity: 0.95

Chemical Structure| 39151-19-4

[ 39151-19-4 ]

1-(3,5-Dimethoxyphenyl)ethanone

Similarity: 0.95

Ethers

Chemical Structure| 586-37-8

[ 586-37-8 ]

3'-Methoxyacetophenone

Similarity: 0.98

Chemical Structure| 43113-94-6

[ 43113-94-6 ]

1-(3-Methoxy-5-methylphenyl)ethanone

Similarity: 0.98

Chemical Structure| 37951-49-8

[ 37951-49-8 ]

3'-Methoxypropiophenone

Similarity: 0.98

Chemical Structure| 611-94-9

[ 611-94-9 ]

(4-Methoxyphenyl)(phenyl)methanone

Similarity: 0.95

Chemical Structure| 39151-19-4

[ 39151-19-4 ]

1-(3,5-Dimethoxyphenyl)ethanone

Similarity: 0.95

Ketones

Chemical Structure| 586-37-8

[ 586-37-8 ]

3'-Methoxyacetophenone

Similarity: 0.98

Chemical Structure| 43113-94-6

[ 43113-94-6 ]

1-(3-Methoxy-5-methylphenyl)ethanone

Similarity: 0.98

Chemical Structure| 37951-49-8

[ 37951-49-8 ]

3'-Methoxypropiophenone

Similarity: 0.98

Chemical Structure| 611-94-9

[ 611-94-9 ]

(4-Methoxyphenyl)(phenyl)methanone

Similarity: 0.95

Chemical Structure| 39151-19-4

[ 39151-19-4 ]

1-(3,5-Dimethoxyphenyl)ethanone

Similarity: 0.95